tiprankstipranks
Carl Zeiss Meditec (DE:AFX)
XETRA:AFX
Germany Market
AFX
Carl Zeiss Meditec
RESEARCH TOOLSreports
Want to see DE:AFX full AI Analyst Report?

Carl Zeiss Meditec (AFX) Ratios

130 Followers

Carl Zeiss Meditec Ratios

DE:AFX's free cash flow for Q2 2026 was €0.49. For the 2026 fiscal year, DE:AFX's free cash flow was decreased by € and operating cash flow was €0.04. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 2.43 2.35 2.13 3.40 3.32
Quick Ratio
 1.37 1.44 1.19 2.48 2.61
Cash Ratio
 0.05 0.05 0.04 0.02 0.01
Solvency Ratio
 0.18 0.20 0.23 0.42 0.46
Operating Cash Flow Ratio
 0.61 0.39 0.43 0.45 0.35
Short-Term Operating Cash Flow Coverage
 5.16 4.80 99.69 5.45 8.68
Net Current Asset Value
€ 2.34M€ -51.44M€ -124.24M€ 1.05B€ 999.13M
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.18 0.18 0.10 0.05
Debt-to-Equity Ratio
 0.29 0.29 0.30 0.14 0.06
Debt-to-Capital Ratio
 0.23 0.22 0.23 0.12 0.06
Long-Term Debt-to-Capital Ratio
 0.18 0.18 0.18 0.04 0.04
Financial Leverage Ratio
 1.59 1.63 1.66 1.40 1.40
Debt Service Coverage Ratio
 2.42 4.20 -28.30 6.24 12.17
Interest Coverage Ratio
 5.14 8.39 -12.10 21.45 44.71
Debt to Market Cap
 0.22 0.14 0.07 0.02 0.01
Interest Debt Per Share
 7.57 7.24 6.73 3.50 1.53
Net Debt to EBITDA
 1.36 1.67 1.47 0.57 0.25
Profitability Margins
Gross Profit Margin
51.82%52.76%52.69%57.71%59.26%
EBIT Margin
8.45%9.90%13.08%20.48%21.71%
EBITDA Margin
11.25%15.57%19.51%24.06%25.35%
Operating Profit Margin
8.52%10.02%8.54%15.66%21.38%
Pretax Profit Margin
7.12%8.70%11.66%19.75%21.20%
Net Profit Margin
5.14%6.34%8.65%13.90%15.45%
Continuous Operations Profit Margin
5.16%6.39%8.72%13.98%15.55%
Net Income Per EBT
72.21%72.83%74.20%70.39%72.84%
EBT Per EBIT
83.55%86.82%136.58%126.11%99.19%
Return on Assets (ROA)
4.20%4.08%5.27%9.57%10.41%
Return on Equity (ROE)
6.69%6.67%8.75%13.45%14.59%
Return on Capital Employed (ROCE)
10.81%8.81%6.24%13.24%17.81%
Return on Invested Capital (ROIC)
8.19%6.32%4.63%9.12%12.82%
Return on Tangible Assets
8.10%7.73%10.49%12.32%13.65%
Earnings Yield
6.19%3.83%2.83%3.92%3.06%
Efficiency Ratios
Receivables Turnover
 4.37 3.22 3.54 1.61 1.39
Payables Turnover
 11.40 9.66 5.33 3.68 4.10
Inventory Turnover
 2.44 2.12 1.82 1.70 2.03
Fixed Asset Turnover
 8.12 6.50 5.84 6.62 8.06
Asset Turnover
 0.82 0.64 0.61 0.69 0.67
Working Capital Turnover Ratio
 3.73 3.23 2.07 1.61 1.58
Cash Conversion Cycle
 181.55 247.91 234.84 342.46 353.24
Days of Sales Outstanding
 83.44 113.33 103.02 226.61 262.11
Days of Inventory Outstanding
 124.84 172.36 200.35 214.91 180.21
Days of Payables Outstanding
 26.74 37.78 68.54 99.06 89.07
Operating Cycle
 208.29 285.69 303.38 441.53 442.31
Cash Flow Ratios
Operating Cash Flow Per Share
 3.53 2.40 2.78 2.80 2.10
Free Cash Flow Per Share
 2.96 1.95 1.07 1.53 1.19
CapEx Per Share
 0.56 0.45 1.71 1.27 0.92
Free Cash Flow to Operating Cash Flow
 0.84 0.81 0.38 0.55 0.56
Dividend Paid and CapEx Coverage Ratio
 2.06 2.28 0.99 1.18 1.16
Capital Expenditure Coverage Ratio
 6.24 5.33 1.62 2.20 2.30
Operating Cash Flow Coverage Ratio
 0.50 0.35 0.40 0.84 1.47
Operating Cash Flow to Sales Ratio
 0.11 0.09 0.12 0.12 0.10
Free Cash Flow Yield
11.45%4.62%1.50%1.85%1.11%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 16.70 26.13 35.37 25.51 32.70
Price-to-Sales (P/S) Ratio
 0.86 1.66 3.06 3.55 5.05
Price-to-Book (P/B) Ratio
 1.12 1.74 3.10 3.43 4.77
Price-to-Free Cash Flow (P/FCF) Ratio
 9.03 21.65 66.46 54.07 90.47
Price-to-Operating Cash Flow Ratio
 7.58 17.59 25.56 29.53 51.07
Price-to-Earnings Growth (PEG) Ratio
 1.75 -1.31 -0.93 -20.98 1.33
Price-to-Fair Value
 1.12 1.74 3.10 3.43 4.77
Enterprise Value Multiple
 9.56 12.31 17.15 15.30 20.17
Enterprise Value
 2.86B 4.27B 6.91B 7.69B 9.73B
EV to EBITDA
 6.56 12.31 17.15 15.30 20.17
EV to Sales
 1.05 1.92 3.35 3.68 5.11
EV to Free Cash Flow
 11.03 25.05 72.69 56.16 91.60
EV to Operating Cash Flow
 9.26 20.35 27.96 30.67 51.70
Tangible Book Value Per Share
 5.71 5.66 4.13 16.74 15.21
Shareholders’ Equity Per Share
 23.98 24.18 22.98 24.14 22.53
Tax and Other Ratios
Effective Tax Rate
 0.27 0.27 0.25 0.29 0.27
Revenue Per Share
 31.17 25.45 23.25 23.36 21.27
Net Income Per Share
 1.60 1.61 2.01 3.25 3.29
Tax Burden
 0.60 0.73 0.74 0.70 0.73
Interest Burden
 0.83 0.88 0.89 0.96 0.98
Research & Development to Revenue
 0.18 0.15 0.17 0.17 0.15
SG&A to Revenue
 0.28 0.28 0.28 0.04 0.04
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.83 1.47 1.38 0.86 0.64
Currency in EUR